Efficacy of oral L-ornithine-L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy. Results of a randomized, lactulose-controlled study

Efficacy of oral L-ornithine-L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy. Results of a randomized, lactulose-controlled study

Despite steady progress in therapeutics of liver disease, portal systemic encephalopathy remains to be a great challenge for clinicians because of the heterogeneity of neuropsychiatric symptoms, multiple risk factors and complexity on achieving a sustained response. We aimed to evaluate the efficacy...

Full description

Bibliographic Details
Main Authors: Jorge Luis Poo, Julieta Góngora, Francisco Sánchez-Ávila, Sergio Aguilar-Castillo, Guillermo García-Ramos, Mario Fernández-Zertuche, Lourdes Rodríguez-Fragoso, Misael Uribe
Format: Article
Language:English
Published: Elsevier 2006-10-01
Series:Annals of Hepatology
Subjects:
Cirrhosis
hyperammonemia
hepatic encephalopathy
L-Ornitin-L-Aspartate
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268119319891

Similar Items

Similar Items